Abstract
The "glucocorticoid cascade hypothesis" for pathological ageing of the brain is supported by strong experimental data, but the clinical correlates are far less clear. The basal ACTH and cortisol secretion have been studied before and after the dexamethasone suppression test in patients in the early stages of clinically probable Alzheimer's disease and in controls, and the results were all normal. These findings do not support the hypothesis that the pathological brain ageing of Alzheimer's type is caused by hyperactivity of the pituitary-adrenal axis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balldin J., Gottfries C. G., Karlsson I., Lindstedt G., Långström G., Wålinder J. Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry. 1983 Sep;143:277–281. doi: 10.1192/bjp.143.3.277. [DOI] [PubMed] [Google Scholar]
- Carnes M., Smith J. C., Kalin N. H., Bauwens S. F. Effects of chronic medical illness and dementia on the dexamethasone suppression test. J Am Geriatr Soc. 1983 May;31(5):269–271. doi: 10.1111/j.1532-5415.1983.tb04869.x. [DOI] [PubMed] [Google Scholar]
- Davous P., Roudier M., Piketty M. L., Abramowitz C., Lamour Y. Pharmacological modulation of cortisol secretion and dexamethasone suppression in Alzheimer's disease. Biol Psychiatry. 1988 Jan 1;23(1):13–24. doi: 10.1016/0006-3223(88)90102-3. [DOI] [PubMed] [Google Scholar]
- Feldman S., Conforti N. Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. Neuroendocrinology. 1980;30(1):52–55. doi: 10.1159/000122974. [DOI] [PubMed] [Google Scholar]
- Georgotas A., McCue R. E., Kim O. M., Hapworth W. E., Reisberg B., Stoll P. M., Sinaiko E., Fanelli C., Stokes P. E. Dexamethasone suppression in dementia, depression, and normal aging. Am J Psychiatry. 1986 Apr;143(4):452–456. doi: 10.1176/ajp.143.4.452. [DOI] [PubMed] [Google Scholar]
- Jacobs H. S., Nabarro J. D. Tests of hypothalamic-pituitary-adrenal function in man. Q J Med. 1969 Oct;38(152):475–491. [PubMed] [Google Scholar]
- Landfield P. W., Waymire J. C., Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science. 1978 Dec 8;202(4372):1098–1102. doi: 10.1126/science.715460. [DOI] [PubMed] [Google Scholar]
- McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
- Pomara N., Oxenkrug G. F., McIntyre I. M., Block R., Stanley M., Gershon S. Does severity of dementia modulate response to dexamethasone in individuals with primary degenerative dementia? Biol Psychiatry. 1984 Oct;19(10):1481–1487. [PubMed] [Google Scholar]
- Raskind M., Peskind E., Rivard M. F., Veith R., Barnes R. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry. 1982 Nov;139(11):1468–1471. doi: 10.1176/ajp.139.11.1468. [DOI] [PubMed] [Google Scholar]
- Sapolsky R. M., Krey L. C., McEwen B. S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986 Aug;7(3):284–301. doi: 10.1210/edrv-7-3-284. [DOI] [PubMed] [Google Scholar]
- Sapolsky R. M., Pulsinelli W. A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science. 1985 Sep 27;229(4720):1397–1400. doi: 10.1126/science.4035356. [DOI] [PubMed] [Google Scholar]